1.Association between thyroid function levels and phenotypes associated with sarcopenia
Jiatong LI ; Yue JIN ; Runjia LIU ; Bowen SONG ; Xiaoqian ZHU ; Nianhu LI
Chinese Journal of Tissue Engineering Research 2025;29(6):1312-1320
BACKGROUND:Several observational studies have found a close relationship between thyroid function levels and sarcopenia,but the causal relationship between thyroid function levels and the onset of sarcopenia is not yet clear. OBJECTIVE:To investigate the causal relationship between thyroid function levels and sarcopenia using a two sample Mendelian randomization method. METHODS:A two sample Mendelian randomization analysis was conducted using genome-wide association study data on thyrotropin,free triiodothyronine,free tetraiodothyronine,subclinical hyperthyroidism,subclinical hypothyroidism,and four related phenotypes of sarcopenia-lefthand grip strength,right hand grip strength,limb lean mass,and gait speed.The inverse-variance weighted method,weighted median method,simple mode method,weighted median estimator method,and MR Egger regression method were used as analysis methods,while heterogeneity test,pleiotropy test,MR-PRESSO,leave-one-out method,funnel plot and other methods were used for sensitivity analysis. RESULTS AND CONCLUSION:Elevated levels of thyroid-stimulating hormone increased left-(β=0.02,SE=0.01,P=0.01)and right-handed grip strength(β=0.02,SE=0.01,P=0.01),an increase in free triiodothyronine decreased left-(β=-0.06,SE=0.02,P=9.5×10-5)and right-handed grip strength(β=-0.07,SE=0.02,P=9.3×10-5),and subclinical hyperthyroidism decreased gait speed(β=-4.4×10-3,SE=1.7×10-3,P=0.01).The sensitivity analysis results were basically consistent with the main analysis results.To conclude,an increase in thyroid-stimulating hormone is a protective factor for sarcopenia,and elevation of free triiodothyronine and subclinical hyperthyroidism may increase the risk of sarcopenia.
2.Predicting BRCA-mutated breast cancer based on a combined clinicopathological and multiparametric MRI features model
Xiaohong CHEN ; Zhiqi YANG ; Bowen YUE ; Yi CHEN ; Jianhui LI ; Xinwei ZHONG ; Hao ZHANG ; Xinhong LIANG ; Weixiong FAN ; Xiaofeng CHEN
Journal of Practical Radiology 2025;41(7):1139-1143
Objective To explore the efficacy of a model combining clinicopathological characteristics and multiparametric MRI features for predicting BRCA-mutated breast cancer(BC).Methods A total of 256 BC patients were retrospectively selected and divided into BRCA mutation group(116 cases)and BRCA wild group(140 cases)based on the BRCA results.Chi-square tests or independ-ent sample t-tests were used to compare the differences in clinicopathological characteristics and multiparametric MRI features between the BRCA mutation group and the wild group.Risk factors for BRCA-mutated BC were identified through univariate and multivariate logistic regression ananlyses,and a combined predictive model was constructed.Receiver operating characteristic(ROC)curve was used to ana-lyze the diagnostic efficacy of the model.Results There were statistically significant differences in T stage,human epidermal growth factor receptor 2(HER-2),Ki-67,non-mass enhancement,enhancement pattern,time-signal intensity curve(TIC)type,and apparent diffusion coefficient(ADC)values between the BRCA mutation group and the wild group.Univariate logistic regression analysis showed that T stage,HER-2,Ki-67,non-mass enhancement,enhancement pattern,TIC type,and ADC values were risk factors for BRCA-mutated BC(P<0.05).Multivariate logistic regression analysis revealed that T stage,HER-2,Ki-67,enhancement pattern,and TIC type were independent risk factors for BRCA-mutated BC(P<0.05).The combined model incorporating T stage,HER-2,Ki-67,enhancement pattern,and TIC type had the best diagnostic efficacy in predicting BRCA-mutated BC,with an area under the curve(AUC)of 0.751.Conclusion The combined model integrating T stage,HER-2,Ki-67,enhancement pattern,and TIC type has good efficacy in predicting BRCA-mutated BC.
3.Predicting BRCA-mutated breast cancer based on a combined clinicopathological and multiparametric MRI features model
Xiaohong CHEN ; Zhiqi YANG ; Bowen YUE ; Yi CHEN ; Jianhui LI ; Xinwei ZHONG ; Hao ZHANG ; Xinhong LIANG ; Weixiong FAN ; Xiaofeng CHEN
Journal of Practical Radiology 2025;41(7):1139-1143
Objective To explore the efficacy of a model combining clinicopathological characteristics and multiparametric MRI features for predicting BRCA-mutated breast cancer(BC).Methods A total of 256 BC patients were retrospectively selected and divided into BRCA mutation group(116 cases)and BRCA wild group(140 cases)based on the BRCA results.Chi-square tests or independ-ent sample t-tests were used to compare the differences in clinicopathological characteristics and multiparametric MRI features between the BRCA mutation group and the wild group.Risk factors for BRCA-mutated BC were identified through univariate and multivariate logistic regression ananlyses,and a combined predictive model was constructed.Receiver operating characteristic(ROC)curve was used to ana-lyze the diagnostic efficacy of the model.Results There were statistically significant differences in T stage,human epidermal growth factor receptor 2(HER-2),Ki-67,non-mass enhancement,enhancement pattern,time-signal intensity curve(TIC)type,and apparent diffusion coefficient(ADC)values between the BRCA mutation group and the wild group.Univariate logistic regression analysis showed that T stage,HER-2,Ki-67,non-mass enhancement,enhancement pattern,TIC type,and ADC values were risk factors for BRCA-mutated BC(P<0.05).Multivariate logistic regression analysis revealed that T stage,HER-2,Ki-67,enhancement pattern,and TIC type were independent risk factors for BRCA-mutated BC(P<0.05).The combined model incorporating T stage,HER-2,Ki-67,enhancement pattern,and TIC type had the best diagnostic efficacy in predicting BRCA-mutated BC,with an area under the curve(AUC)of 0.751.Conclusion The combined model integrating T stage,HER-2,Ki-67,enhancement pattern,and TIC type has good efficacy in predicting BRCA-mutated BC.
4.Diagnostic value of combined model based on clinicopathological and MRI features in BRCA-mutated ovarian cancer
Hao ZHANG ; Xiaohong CHEN ; Xinwei ZHONG ; Yi CHEN ; Bowen YUE ; Shourang CHEN ; Wenzhong HOU ; Zhiqi YANG ; Xiaofeng CHEN
Journal of Practical Radiology 2025;41(2):246-250
Objective To explore the diagnostic value of a combined model based on clinicopathological and MRI features in BRCA-mutated ovarian cancer.Methods The data of 132 patients with ovarian cancer who underwent pathology and BRCA gene tes-ting were analyzed retrospectively,including 52 cases of BRCA mutation group and 80 cases of BRCA wild group.The differences of MRI features and clinicopathological features between BRCA mutation group and BRCA wild group were compared.Binary logistic regression was used to construct a joint prediction model and analyze its diagnostic efficiency.Results There were significant differ-ences in cytokeratin 7(CK7),estrogen receptor(ER),Ki-67 and lymphovascular invasion(LVI)between the BRAC mutation group and the BRAC wild group(P<0.05).Univariate analysis showed that CK7,ER,Ki-67,LVI and the apparent diffusion coefficient(ADC)value of the cystic part of tumor were risk factors for BRCA-mutated ovarian cancer.The combined model based on CK7,ER,Ki-67,LVI,and the ADC value of the cystic part of tumor for the diagnosis of BRCA-mutated ovarian cancer had an area under the curve(AUC)of 0.765.Conclusion CK7,ER,Ki-67,LVI and the ADC value of the cystic part of tumor are risk factors for BRCA-mutated ovarian cancer.The combined model based on the above characteristics demonstrates good diagnostic efficacy for BRCA-mutated ovarian cancer.
5.Drug resistance and molecular characteristics of Staphylococcus aureus strains from ICU environment based on whole genome sequencing
Yanru LIANG ; Bowen YANG ; Yue ZHANG ; Tongsheng XU ; Bing ZHAO ; Xiao WANG
Chinese Journal of Nosocomiology 2025;35(14):2170-2175
OBJECTIVE To investigate the distribution,drug resistance and molecular characteristics of the Staph-ylococcus aureus strains isolated from intensive care unit(ICU)environment in some hospitals of Shanghai Pudong New Area so as to provide bases for prevention and control of infections.METHODS The specimens were collected from ICU environment of 8 medical institutions in Pudong District in 2019 and 2023,the S.aureus strains were i-solated and identified.The drug susceptibility testing was performed by microbroth dilution method.The drug re-sistance genes and virulence genes were predicted based on virulence factors of bacterial pathogens,the compre-hensive antibiotic resistance database(mcmaster.ca)and PubMLST,multilocus sequence typing(MLST)and phylogenetic analysis were performed.RESULTS Totally 3408 samples were collected,and the isolated S.aureus strains accounted for 1.29%(44/3408);the isolated strains form both the shared articles and the articles that health care workers directly contact accounted for 20.45%.The drug resistance rate to penicillin was highest(72.73%,32/44);the strains were completely susceptible to vancomycin,rifampicin,sulfamethoxazole-trime-thoprim,daptomycin and nitrofurantoin.The methicillin-resistant Staphylococcus aureus(MRSA)strains accoun-ted for 25.00%.The multi-drug resistance rate was 40.91%.The strains carried 26 types of drug resistance genes in total,covering 9 categories;the carrying rate of fluroquinolones resistance gene nor A was 100.00%.The strains carried 12 types of enterotoxin genes,the carrying rate of sea gene was highest(50.00%,22/44),some of the strains carried lukS-PV,lukF-PV and tsst gene.There were 14 types of sequence type(ST),dominated by ST7(13/44,29.55%),and novel ST type ST9342 was discovered.The phylogenetic analysis showed that all of the strains were divided into 2 major branches,and the strains with the same ST type were phylogenetically close on the evolutionary tree.CONCLUSIONS The S.aureus strains are prevalent in ICU environment and are highly re-sistant to antibiotics.The strains exhibit various ST types,which,to a certain degree,is associated with the path-ogenicity.
6.Drug resistance and molecular characteristics of Staphylococcus aureus strains from ICU environment based on whole genome sequencing
Yanru LIANG ; Bowen YANG ; Yue ZHANG ; Tongsheng XU ; Bing ZHAO ; Xiao WANG
Chinese Journal of Nosocomiology 2025;35(14):2170-2175
OBJECTIVE To investigate the distribution,drug resistance and molecular characteristics of the Staph-ylococcus aureus strains isolated from intensive care unit(ICU)environment in some hospitals of Shanghai Pudong New Area so as to provide bases for prevention and control of infections.METHODS The specimens were collected from ICU environment of 8 medical institutions in Pudong District in 2019 and 2023,the S.aureus strains were i-solated and identified.The drug susceptibility testing was performed by microbroth dilution method.The drug re-sistance genes and virulence genes were predicted based on virulence factors of bacterial pathogens,the compre-hensive antibiotic resistance database(mcmaster.ca)and PubMLST,multilocus sequence typing(MLST)and phylogenetic analysis were performed.RESULTS Totally 3408 samples were collected,and the isolated S.aureus strains accounted for 1.29%(44/3408);the isolated strains form both the shared articles and the articles that health care workers directly contact accounted for 20.45%.The drug resistance rate to penicillin was highest(72.73%,32/44);the strains were completely susceptible to vancomycin,rifampicin,sulfamethoxazole-trime-thoprim,daptomycin and nitrofurantoin.The methicillin-resistant Staphylococcus aureus(MRSA)strains accoun-ted for 25.00%.The multi-drug resistance rate was 40.91%.The strains carried 26 types of drug resistance genes in total,covering 9 categories;the carrying rate of fluroquinolones resistance gene nor A was 100.00%.The strains carried 12 types of enterotoxin genes,the carrying rate of sea gene was highest(50.00%,22/44),some of the strains carried lukS-PV,lukF-PV and tsst gene.There were 14 types of sequence type(ST),dominated by ST7(13/44,29.55%),and novel ST type ST9342 was discovered.The phylogenetic analysis showed that all of the strains were divided into 2 major branches,and the strains with the same ST type were phylogenetically close on the evolutionary tree.CONCLUSIONS The S.aureus strains are prevalent in ICU environment and are highly re-sistant to antibiotics.The strains exhibit various ST types,which,to a certain degree,is associated with the path-ogenicity.
7.Diagnostic value of combined model based on clinicopathological and MRI features in BRCA-mutated ovarian cancer
Hao ZHANG ; Xiaohong CHEN ; Xinwei ZHONG ; Yi CHEN ; Bowen YUE ; Shourang CHEN ; Wenzhong HOU ; Zhiqi YANG ; Xiaofeng CHEN
Journal of Practical Radiology 2025;41(2):246-250
Objective To explore the diagnostic value of a combined model based on clinicopathological and MRI features in BRCA-mutated ovarian cancer.Methods The data of 132 patients with ovarian cancer who underwent pathology and BRCA gene tes-ting were analyzed retrospectively,including 52 cases of BRCA mutation group and 80 cases of BRCA wild group.The differences of MRI features and clinicopathological features between BRCA mutation group and BRCA wild group were compared.Binary logistic regression was used to construct a joint prediction model and analyze its diagnostic efficiency.Results There were significant differ-ences in cytokeratin 7(CK7),estrogen receptor(ER),Ki-67 and lymphovascular invasion(LVI)between the BRAC mutation group and the BRAC wild group(P<0.05).Univariate analysis showed that CK7,ER,Ki-67,LVI and the apparent diffusion coefficient(ADC)value of the cystic part of tumor were risk factors for BRCA-mutated ovarian cancer.The combined model based on CK7,ER,Ki-67,LVI,and the ADC value of the cystic part of tumor for the diagnosis of BRCA-mutated ovarian cancer had an area under the curve(AUC)of 0.765.Conclusion CK7,ER,Ki-67,LVI and the ADC value of the cystic part of tumor are risk factors for BRCA-mutated ovarian cancer.The combined model based on the above characteristics demonstrates good diagnostic efficacy for BRCA-mutated ovarian cancer.
8.The current status of treatment for aortic diseases in China
Chang SHU ; Bowen FAN ; Yue ZHUO ; Mingyao LUO ; Kun FANG
Chinese Journal of General Surgery 2024;39(9):657-661
With the population aging, the prevalence rate of cardiovascular diseases in China continues to rise, among which, the mortality rate of aortic diseases is high, the treatment is difficult, and the risk is high. In recent years, the surgical treatment of aortic diseases in China has developed rapidly, and the overall scale has been increasing. This paper introduces the current status of treatment of aortic diseases in China, analyzes the medical quality of endovascular surgery and open surgery, including the number of operations, patient characteristics, mortality, readmission rate and other indicators, and compares the differences among different regions. In addition, advances in the treatment of aortic disease are discussed, including surgical methods, evaluation of effectiveness, and application of new technologies. Overall, China has made some progress in the treatment of aortic diseases, but it still faces the challenge of uneven distribution of medical resources and improvement of medical quality.
9.Study on the Rule and Mechanism of Traditional Chinese Medicine in Treating Chronic Viral Hepatitis B
Bowen LIU ; Yue WU ; Xiaobin LI
Journal of Zhejiang Chinese Medical University 2024;48(8):1017-1032
[Objective]Based on data mining,network pharmacology and molecular docking technology,to explore the rule and mechanism of Chinese medicine in the treatment of chronic viral hepatitis B.[Methods]Clinical research literature on Chinese medicine treatment of chronic viral hepatitis B collected in China National Knowledge Internet(CNKI),Wanfang Database and VIP Database from establishment to September 12,2022,were searched,and the data were standardized and classified.Meanwhile,Excel 2019,Cytoscape 3.8.0 and Qrigin 2021 software were used to analyze the frequency,association rules and systematic clustering of the Chinese medicine compounds meeting the inclusion criteria,and obtain medication rules and core prescriptions.The Traditional Chinese Medicine System Pharmacology Database and Analysis Platform(TCMSP),Human Gene database(GeneCards)and Online Human Mendelian Inheritance in Man(OMIM)database were used to obtain core prescription active ingredients,therapeutic targets and disease-related targets,respectively.The STRING 11.5 database and Cytoscape 3.8.0 software were used for network visualization,and the Metascape database was used for gene ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis,AutoDock Vina 1.2.3 software were used for molecular docking.[Results]A total of 192 prescriptions were included,including 225 drugs.The drug properties were cold,warm and normal,and the drug flavors were bitter,sweet and acrid,mostly attributed to liver,lung,stomach and spleen channels.The main types of action were deficiency tonic,heat-clearing,diuretic and dehydrating.Association analysis showed that the common compatibility was Atractylodes macrocephala-Curcumae radix-Poria cocos-Salvia miltiorrhiza,Atractylodes macrocephala-Curcumae radix-Poria cocos,Astragalus membranaceus-Phyllanthus urinaria-Salvia miltiorrhiza.The clustering analysis was divided into 4 categories,and the clustering effect was good.Network pharmacology and molecular docking suggested 201 kinds of active ingredients,4 208 targets,2 920 disease targets,104 overlapping targets of drug diseases,and 1 369 biological processes(BP),celluar component(CC)87,molecular function(MF)120 were identified by GO functional enrichment analysis,and KEGG pathway enrichment analysis identified 190 pathways,the conformation of the core components and core target molecular bonding results tended to be stable.[Conclusion]By using literature data mining,network pharmacology and molecular docking technology,the drug use rules and core formulations of traditional Chinese medicine in the treatment of chronic viral hepatitis B were summarized,and the potential therapeutic targets and signaling pathways of the core formulations in the intervention of chronic viral hepatitis B were further explored,and the molecular docking results were good,which could provide ideas and methods for the future research of chronic viral hepatitis B.
10.Diagnostic value of combining DCE-MRI perfusion parameters,ADC value and clinical feature model for HER-2 over expressed breast cancer
Shourang CHEN ; Zhiqi YANG ; Yi CHEN ; Bowen YUE ; Yabao CHENG ; Weixiong FAN ; Xiaofeng CHEN
Journal of Practical Radiology 2024;40(7):1083-1086,1110
Objective To investigate the diagnostic efficiency of patients with human epidermal growth factor receptor-2(HER-2)over expressed breast cancer via combining the dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)perfusion parameters,apparent diffusion coefficient(ADC)value and clinical feature model.Methods A total of 197 breast cancer patients who underwent DCE-MRI and diffusion weighted imaging(DWI)scans were analyzed retrospectively,including 47 breast cancer patients with HER-2 over expressed and 150 breast cancer patients with non-HER-2 over expressed.The t-test or chi-square test was used to compare the DCE-MRI perfusion parameters[Ktrans,Kep,Ve,W-in,W-out,and time to peak(TTP)],ADC value,and clinical feature between the two groups.The diagnostic efficiency of the models were analyzed via receiver operating characteristic(ROC)curves.Results There were significant difference in the maximum tumor diameter,minimum tumor diameter,T stage,N stage,Kep,W-in,and ADC value between HER-2 over expressed breast cancer and non-HER-2 over expressed breast cancer groups(P<0.05).The proposed combined model,which included the combined maximum tumor diameter,minimum tumor diameter,T stage,N stage,Kep,W-in,and ADC value,showed a better diagnostic efficiency with area under the curve(AUC)(AUC=0.763)than the clinical model(AUC=0.634)based on the combined maximum tumor diameter,minimum tumor diameter,T stage,and N stage,and the imaging model(AUC=0.715)based on the combined Kep,W-in and ADC value.Conclusion The maximum tumor diameter,minimum tumor diameter,T stage,N stage,Kep,W-in,and ADC value may be associated with HER-2 over expressed breast cancer.Combining all above parameters can improve the diagnostic ability of breast cancer patients with HER-2 over expressed.

Result Analysis
Print
Save
E-mail